<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35149883</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-1920</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neuroradiology</Title>
          <ISOAbbreviation>Neuroradiology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison between 3D SPACE FLAIR and 3D TSE FLAIR in Menière's disease.</ArticleTitle>
        <Pagination>
          <StartPage>1011</StartPage>
          <EndPage>1020</EndPage>
          <MedlinePgn>1011-1020</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00234-022-02913-0</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Heavily T2-weighted 3D FLAIR (hT<sub>2</sub>w-3D-FLAIR) sequence with constant flip angle (CFA) has been reported as being more sensitive to low concentrations of gadolinium (Gd) enabling endolymphatic hydrops (EH) visualization. The purpose of this study was to compare signal-to-noise (SNR) ratio, detection rate of EH, and increased perilymphatic enhancement (PE) as well as diagnostic accuracy in diagnosing definite Menière's disease (MD), using 3D-SPACE FLAIR versus conventional 3D-TSE FLAIR.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study included 29 definite MD patients who underwent a 4-h delayed intravenous (IV) Gd-enhanced 3D-TSE FLAIR and 3D-SPACE FLAIR MRI between February 2019 and February 2020. MR images were qualitatively and quantitatively analyzed twice by 2 experienced head and neck radiologists. Qualitative assessment included grading of cochlear and vestibular EH and visual comparison of PE. Quantitative assessment of PE was performed by placing a region of interest (ROI) and ratio calculation in the basal turn of the cochlea and the brainstem.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The intra- and inter-reader reliability for grading of EH and PE was excellent (0.7 &lt; kappa &lt; 0.9) for 3D-SPACE FLAIR and exceeded the values for 3D-TSE FLAIR (0.5 &lt; kappa &lt; 0.9) The combination of EH and visual assessment of PE has the highest diagnostic accuracy in diagnosing definite MD on 3D-SPACE FLAIR with a sensitivity of 0.91 and a specificity of 0.98 resulting in a sensitivity raise of 6% compared to 3D-TSE FLAIR.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Four-hour delayed IV Gd-enhanced 3D-SPACE FLAIR sequence has a higher sensitivity and reproducibility than 3D-TSE FLAIR for the visualization of EH and increased PE in definite MD patients.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bernaerts</LastName>
            <ForeName>Anja</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-8652-7967</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium. Anja.Bernaerts@gza.be.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janssen</LastName>
            <ForeName>Nick</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wuyts</LastName>
            <ForeName>Floris L</ForeName>
            <Initials>FL</Initials>
            <AffiliationInfo>
              <Affiliation>Lab for Equilibrium Investigations and Aerospace, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>European Institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blaivie</LastName>
            <ForeName>Cathérine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>European Institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vanspauwen</LastName>
            <ForeName>Robby</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>European Institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Dinther</LastName>
            <ForeName>Joost</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>European Institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zarowski</LastName>
            <ForeName>Andrzej</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>European Institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Offeciers</LastName>
            <ForeName>Erwin</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>European Institute for ORL-HNS, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deckers</LastName>
            <ForeName>Filip</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Casselman</LastName>
            <ForeName>Jan W</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, AZ Sint-Jan Hospital, Ruddershove 10, 8000, Bruges, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Foer</LastName>
            <ForeName>Bert</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, GZA Hospitals Antwerp, Oosterveldlaan 24, 2610, Antwerp, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Neuroradiology</MedlineTA>
        <NlmUniqueID>1302751</NlmUniqueID>
        <ISSNLinking>0028-3940</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>AU0V1LM3JT</RegistryNumber>
          <NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018159" MajorTopicYN="Y">Endolymphatic Hydrops</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005682" MajorTopicYN="N">Gadolinium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008575" MajorTopicYN="Y">Meniere Disease</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Diagnosis</Keyword>
        <Keyword MajorTopicYN="N">Endolymphatic hydrops</Keyword>
        <Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">Menière disease</Keyword>
        <Keyword MajorTopicYN="N">Perilymph</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>5</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35149883</ArticleId>
        <ArticleId IdType="pmc">PMC9005391</ArticleId>
        <ArticleId IdType="doi">10.1007/s00234-022-02913-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s00234-022-02913-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Naganawa S, Nakashima T. Visualization of endolymphatic hydrops with MR imaging in patients with Ménière’s disease and related pathologies: current status of its methods and clinical significance. Jpn J Radiol. 2014;32(4):191–204. doi: 10.1007/s11604-014-0290-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11604-014-0290-4</ArticleId>
            <ArticleId IdType="pubmed">24500139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa R, Raposo F, Guerreiro C, Berhanu D, Eça T, Campos J, Luis L. Magnetic Resonance imaging and Ménière’s disease-unavoidable alliance. Neuroradiology. 2021;63(11):1749–1763. doi: 10.1007/s00234-021-02744-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00234-021-02744-5</ArticleId>
            <ArticleId IdType="pubmed">34142211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernaerts A, Vanspauwen R, Blaivie C, van Dinther J, Zarowski A, Wuyts FL, Vanden Bossche S, Offeciers E, Casselman JW, De Foer B. The value of four stage vestibular hydrops and asymmetric perilymphatic enhancement in the diagnosis of Menière’s disease on MRI. Neuroradiology. 2019;61(4):421–429. doi: 10.1007/s00234-019-02155-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00234-019-02155-7</ArticleId>
            <ArticleId IdType="pmc">PMC6431299</ArticleId>
            <ArticleId IdType="pubmed">30719545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connor SEJ, Pai I. Endolymphatic hydrops magnetic resonance imaging in Ménière’s disease. Clinical Radiology. 2021;76(1):76.e1–76.e.19. doi: 10.1016/j.crad.2020.07.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.crad.2020.07.021</ArticleId>
            <ArticleId IdType="pubmed">32892985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Steekelenburg JM, van Weijnen A, de Pont LMH, Vijlbrief OD, Bommeljé CC, Koopman JP, Verbist BM, Blom HM, Hammer S. Value of endolymphatic hydrops and perilymph signal intensity in suspected Ménière disease. AJNR Am J Neuroradiol. 2020;41(3):529–534. doi: 10.3174/ajnr.A6410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3174/ajnr.A6410</ArticleId>
            <ArticleId IdType="pmc">PMC7077918</ArticleId>
            <ArticleId IdType="pubmed">32029469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Touska P, Connor SEJ. Imaging of the temporal bone. Clin Radiol. 2020;75(9):685–674. doi: 10.1016/j.crad.2020.06.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.crad.2020.06.013</ArticleId>
            <ArticleId IdType="pubmed">32690241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3Tesla. Eur Radiol. 2008;18(5):920–924. doi: 10.1007/s00330-008-0854-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-008-0854-8</ArticleId>
            <ArticleId IdType="pubmed">18324405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of Ménière’s disease after intravenous administration of single-dose gadodiamide: utility of subtraction images with different inversion time. Magn Reson Med Sci. 2012;11(3):213–219. doi: 10.2463/mrms.11.213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2463/mrms.11.213</ArticleId>
            <ArticleId IdType="pubmed">23037568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of Menière’s disease by subtraction of MR cisternography from positive perilymph image. Magn Reson Med Sci. 2012;11(4):303–309. doi: 10.2463/mrms.11.303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2463/mrms.11.303</ArticleId>
            <ArticleId IdType="pubmed">23269018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. MR Imaging of Ménière’s disease after combined intratympanic and intravenous injection of gadolinium using HYDROPS2. Magn Reson Med Sci. 2014;13(2):133–137. doi: 10.2463/mrms.2013-0061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2463/mrms.2013-0061</ArticleId>
            <ArticleId IdType="pubmed">24769636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nahmani S, Vaussy A, Hautefort C, Guichard JP, Guillonet A, Houdart E, Attyé A, Eliezer M. Comparison of enhancement of the vestibular perilymph between variable and constant flip angle-delayed 3D-FLAIR sequences in Menière disease. AJNR Am J Neuroradiol. 2020;41(4):706–711. doi: 10.3174/ajnr.A6483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3174/ajnr.A6483</ArticleId>
            <ArticleId IdType="pmc">PMC7144642</ArticleId>
            <ArticleId IdType="pubmed">32193190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Kawai H, Sone M, Nakashima T. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci. 2010;9(2):73–80. doi: 10.2463/mrms.9.73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2463/mrms.9.73</ArticleId>
            <ArticleId IdType="pubmed">20585197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A. Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Diagnostic criteria for Menière’s disease. J Vestib Res. 2015;25(1):1–7. doi: 10.3233/VES-150549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/VES-150549</ArticleId>
            <ArticleId IdType="pubmed">25882471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Komada T, Fukatsu H, Ishigaki T, Takizawa Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D FLAIR sequence at 3 Tesla. Eur Radiol. 2006;16:733–737. doi: 10.1007/s00330-005-0046-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-005-0046-8</ArticleId>
            <ArticleId IdType="pubmed">16267664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Ménière’s disease after single-dose intravenous gadolinium-based contrast medium: timing of optimal enhancement. Magn Reson Med Sci. 2012;11(1):43–51. doi: 10.2463/mrms.11.43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2463/mrms.11.43</ArticleId>
            <ArticleId IdType="pubmed">22450386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou J, Chen L, Li H, Zhang G, Pyykkö I, Lu J (2021). High-quality imaging of endolymphatic hydrops acquired in 7 minutes using sensitive hT(2)W-3D-FLAIR reconstructed with magnitude and zero-filled interpolation. Eur Arch Otorhinolaryngol Jun 18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8986670</ArticleId>
            <ArticleId IdType="pubmed">34145490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato Y, Bokura K, Taoka T, Naganawa S. Increased signal intensity of low-concentration gadolinium contrast agent by longer repetition time in heavily T2-weighted-3D-FLAIR. Jpn J Radiol. 2019;37(5):431–435. doi: 10.1007/s11604-019-00828-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11604-019-00828-0</ArticleId>
            <ArticleId IdType="pubmed">30863972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Pont LMH, van Steekelenburg JM, Verhagen TO, Houben M, Goeman JJ, Verbist BM, van Buchem MA, Bommeljé CC, Blom HM, Hammer S. Hydropic ear disease: correlation between audiovestibular symptoms, endolymphatic hydrops and blood-labyrinth barrier impairment. Front Surg. 2021;4(8):758947. doi: 10.3389/fsurg.2021.758947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fsurg.2021.758947</ArticleId>
            <ArticleId IdType="pmc">PMC8601159</ArticleId>
            <ArticleId IdType="pubmed">34805261</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
